Video

Dr Abby Statler: African American Patients With AML Exhibit Higher Kidney Test Abnormalities

When we looked at the pre-treatment creatinine data, we found that African Americans were more likely to have abnormal results and white patients were more likely to have normal results–these differences were statistically significant, said Abby Statler, PhD, MPH, MA, research associate at Cleveland Clinic.

When we looked at the pre-treatment creatinine data, we found that African Americans were more likely to have abnormal results and white patients were more likely to have normal results—these differences were statistically significant, said Abby Statler, PhD, MPH, MA, research associate at Cleveland Clinic.

Transcript

What did you find in your study of African American patients with AML with abnormal kidney tests?

So, when we looked at the pre-treatment creatinine data, and creatinine measures your kidney function, we found that African Americans were more likely to have abnormal results and white patients are more likely to have normal results—these differences were statistically significant. Additionally, when we looked at creatinine clearance data, again, a measure for kidney function, African Americans again had worse results than the white patient population. Again, suggesting that their kidney function is indeed worse than the white patient population. So, across the full cohort, 56% of the patients had some sort of renal dysfunction; but this proportion was higher among African Americans–63% of which had some sort of renal function abnormality that could have potentially excluded them from a clinical trial, but our outcomes suggest that minor renal dysfunction is not associated with clinical outcomes. Therefore, this might not be a reason alone to be excluding patients from clinical trials.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Nicolas Ferreyros, managing director, Community Oncology Alliance
Dr Ibrahim Aldoss
Jody Agena, PharmD, MBA, director of pharamcy operations, Virginia Cancer Specialists
Rachel Rohaidy, MD
Mansi Shah, MD
Miriam Freimer, MD
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Dr Pankit Vachhani
Dr Ibrahim Aldoss
Dr Pankit Vachhani
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo